Login to Your Account



Financings Roundup

Cyclacel Seeks to Raise $22M for Phase III-Ready AML Drug

By Catherine Hollingsworth


Wednesday, October 6, 2010
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription